Virus-Like Particles as vaccine antigens and adjuvants: application to chronic disease, cancer immunotherapy and infectious disease preventive strategiesGerardo Guillén, Luís Herrera, Enrique V. Iglesias et al.|Procedia in Vaccinology|2010Cited by 21
Virus-like particles as nanovaccine candidatesGerardo Guillén, Luis Gabriel González Herrera, Julio Aguilar et al.|Advances in Natural Sciences Nanoscience and Nanotechnology|2013Cited by 6
Development of a technological framework for using virus-like particles as adjuvants in prophylactic and therapeutic vaccines: demonstration of effect in animal models and humansGerardo Guillén, Luís Herrera, Julio Aguilar et al.|DOAJ (DOAJ: Directory of Open Access Journals)|2011Cited by 0